Ten single benzyl phenyl ethers were synthesized and evaluated as human immunodeficiency virus-1 (HIV-1) inhibitors in vitro for the first time. Among these compounds, especially 4-nitrobenzyl phenyl ether (3h) exhibited the highest anti-HIV-1 activity with EC50 (concentration of drug that reduces syncytia formation by 50%) value of 5.96 μg/ml and therapeutic index value of 18.32. The preliminary structure-activity relationships of these benzyl phenyl ethers were also described. © 2009 Pharmaceutical Society of Japan.
CITATION STYLE
Dai, H. L., Liu, W. Q., Xu, H., Yang, L. M., Lv, M., & Zheng, Y. T. (2009). Anti human immunodeficiency virus-1 (HIV-1) agents 1. discovery of benzyl phenyl ethers as new HIV-1 inhibitors in vitro. Chemical and Pharmaceutical Bulletin, 57(1), 84–86. https://doi.org/10.1248/cpb.57.84
Mendeley helps you to discover research relevant for your work.